Royal Philips has unveiled its newest connected solution, Trilogy Evo, the only portable life support ventilator platform designed to stay with patients to provide consistent therapy and monitoring as they change care environments and when their condition changes.
[maxbutton id=”1″ url=”http://info.respiratory-therapy.com/regform” text=”SUBSCRIBE TO NEWS” ]
Philips introduced the product at ERS 2018. Trilogy Evo is not yet available — the company projects initial market introduction into select EU countries in mid-2019 with other markets to follow thereafter upon registration approvals. FDA 510k is currently pending for US and market introduction will occur upon approval which is also projected mid-2019.
Chronic conditions such as COPD can be difficult to manage due to complex care plans, large care teams, and frequent readmissions. Integrated with Care Orchestrator, Philips’ sleep and respiratory care cloud-based management system, Trilogy Evo will help to ease this burden by allowing physicians, clinicians, and care providers to collaborate and coordinate care from hospital to home by storing their patient prescription and therapy information in a single secure location.
“Worldwide, chronic conditions are on the rise, presenting continually growing care challenges. Time and again, we have seen the positive impact that connected care can have not only on patients, but on the care teams that serve them,” said John Frank, Business Leader for Sleep and Respiratory Care at Philips. “With effective treatment options, chronic respiratory conditions can be managed effectively. Trilogy Evo is our next evolution of work in connected care solutions, making therapy management for chronic conditions easier and more efficient.”
